Strumento inattivo

Altre lingue Orchard Therapeutics plc

Azioni

ORTX

US68570P2002

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

FDA Approves First Gene Therapy To Treat Children With Metachromatic Leukodystrophy	03/04
FDA approves innovative gene therapy for MLD	20/03
Orchard Therapeutics Outlines U.S. Launch Plans for Lenmeldy™ (atidarsagene autotemcel), the Only Approved Therapy for Children with Early-onset Metachromatic Leukodystrophy	20/03
Orchard Therapeutics Receives FDA Approval of Lenmeldy™ (atidarsagene autotemcel), the Only Therapy for Eligible Children with Early-onset Metachromatic Leukodystrophy in the U.S.	18/03
Orchard Therapeutics Receives FDA Approval of Lenmeldy? (atidarsagene autotemcel)	18/03
Orchard Therapeutics Announces First Patient Randomized in Registrational Trial of OTL-203 for MPS-I Hurler Syndrome	05/02
Orchard Therapeutics Announces First Patient Randomized in Registrational Trial of OTL-203 for MPS-I Hurler Syndrome	05/02
Orchard Therapeutics Announces Multiple Presentations at the 20th Annual WORLDSymposium	02/02
Kyowa Kirin Co., Ltd - Notice regarding Completion of Share Acquisition of Orchard Therapeutics plc	26/01
Japanese Shares Skid as Inflation Slows Faster-than-Expected in January	26/01
Kyowa Kirin Acquires All Outstanding Shares of Orchard Therapeutics	26/01
Orchard Therapeutics Announces Agreement with the Beneluxa Consortium Enabling Reimbursed Access to Libmeldy	25/01
Orchard Therapeutics plc Announces Board Changes	24/01
Orchard Therapeutics Completes Sale to Japan's Kyowa Kirin	24/01
Kyowa Kirin successfully completes acquisition of Orchard Therapeutics, a global gene therapy leader for rare diseases	24/01
Orchard Therapeutics plc(NasdaqCM:ORTX) dropped from NASDAQ Composite Index	24/01
Kyowa Kirin Co., Ltd. completed the acquisition of Orchard Therapeutics plc from RA Capital Management, L.P., Deep Track Capital, LP, Zentree Investment Management Pte. Ltd. and others.	24/01
Orchard Therapeutics’ Gene Therapy Gets Swiss Regulatory Approval	11/12
Orchard Therapeutics Receives Swissmedic Approval for Libmeldy in Early-onset MLD	11/12
Orchard Therapeutics Receives Swiss Agency for Therapeutic Products Approval for Libmeldy in Early-Onset Metachromatic Leukodystrophy	11/12

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Orchard Therapeutics plc

Azioni

ORTX

US68570P2002

Altre lingue

Filtri